2D structure from PubChem open data (CID 720878). Archive label only.
Key takeaways
Bemitil (bemethyl / Metaprot) is the benzimidazole actoprotector scaffold in this archive. Adamantane actoprotectors such as bromantane sit on a different scaffold.
Mapped animal work clusters on traumatic brain injury and hypoxia adaptation, bronchopulmonary inflammation immunology, and lipid-peroxidation / antioxidant readouts under stress.
Detailed pharmacology is dense in the Russian military-pharmacology circle (Zarubina-Shabanov and related groups); PubMed also indexes biotransformation and doping-control titles that sit beside that core.
What it is
Bemitil sits in the actoprotector line that grew out of Soviet military and sports pharmacology: the Kirov Military Medical Academy benzimidazole programme of the 1960s onward.
It is the benzimidazole scaffold in this archive (sold historically as Metaprot / Bemaktor). Bromantane and other adamantane actoprotectors use a different scaffold.
We feature it because the mapped animal pharmacology lines up across hypoxia, inflammation, and brain-injury models, and it is one of the better-documented compounds in this research tradition.
What the literature describes
Themed chapters drawn only from papers already mapped on this dossier. Archive map. No medical advice.
Brain injury and hypoxia adaptation
In rat traumatic brain injury models, bemitil is described as producing defensive functional-metabolic changes; papers also report it can potentiate piracetam’s nootropic effect in that setting.
After interval hypoxic training in rats, post-session bemitil is reported to enhance adaptive metabolic changes in brain and prolong individual sensitivity to hypoxia.
In turpentine-induced bronchopulmonary inflammation in rats, bemitil monotherapy is reported to restore immunological parameters toward intact-animal levels; combinations with other immunomodulators are also described.
Most of the detailed animal work traces to a small cluster of Russian military-pharmacology labs (Zarubina-Shabanov and related groups), with consistent protocols across papers. That circle is where the densest pharmacology lives.
PubMed also indexes biotransformation, pharmacokinetics, and doping-control titles that sit beside the core animal series.
Open limits
Core animal series are concentrated in a small lab cluster with shared protocols. How should same-protocol density be read?
Where does the heat-load and combination story with bromantane sit relative to single-agent series?
How do doping-control analytical papers relate to the older antihypoxant pharmacology without collapsing the two genres?
Russian full-text papers
CyberLeninka full text from the archive corpus.
2024ПЕРСПЕКТИВЫ МЕДИЦИНСКОГО ПРИМЕНЕНИЯ АДАПТОГЕНОВ РАСТИТЕЛЬНОГО ПРОИСХОЖДЕНИЯCyberLeninka
2021ИССЛЕДОВАНИЕ ПРОИЗВОДНОГО 3-ОКСИПИРИДИНА НА БЕЛКОВООБРАЗОВАТЕЛЬНЫЕ, ПИГМЕНТНЫЕ, ЛИПИДНЫЕ И ФЕРМЕНТНЫЕ ПОКАЗCyberLeninka
2019Повышение физической выносливости у животных препаратами с тиомочевинной группировкой (обзор литературы)CyberLeninka
2019Сравнительная гепатопротекторная эффективность оксиметилурацила и бемитила при токсическом поражении печениCyberLeninka
2019Сравнительный анализ актопротекторных свойств новых химических соединенийCyberLeninka
2018Актопротекторный эффект новых химических соединений в обычных условиях и после воздействия гипертермииCyberLeninka
2018Влияние нового производного аминоэтанола и дикарбоновых кислот на физическую работоспособность при аэробныхCyberLeninka
2018Оценка функционального состояния соматосенсорной коры мозга у крыс при однократном введении бемитилаCyberLeninka
2018Экспериментальное изучение актопротекторных свойств медьсодержащих производных никотиновой кислотыCyberLeninka
2016Влияние препарата афобазол на состояние беременных самок и развитие потомства в онтогенезеCyberLeninka
2016Современные подходы к лечению постинфекционной астении у детей и подростковCyberLeninka
12 from corpus · more on Papers
Also on PubMed
1991[Effectiveness of bemitil in recurrent erysipelas].PubMed
2021Investigation of Bemethyl Biotransformation Pathways by Combination of LC-MS/HRMS and In Silico Methods. doi:10.3390/ijms22169021PubMed
2018Detection of bemitil and its metabolite in urine by means of LC-MS/MS in view of doping control analysis. doi:10.1002/dta.2524PubMed
2015Antioxidant Effect of Polyoxidonium and Metaprot during Bronchopulmonary Inflammation in Rats. doi:10.1007/s10517-015-3137-9PubMed
2015Pharmaceutical Composition for Improving Physical Working Capacity. doi:10.1007/s10517-015-3094-3PubMed
2014[Possibilities of the pharmacological correction of adaptive reactions of human organism in short-term moving from middle to high altitude].PubMed
2012[Protective effects of metaprot and ethomerzol in carbophos intoxications].PubMed
2011[Pharmacokinetics of domestic actoprotector drug Metaprot in healthy volunteers].PubMed
8 curated · weakly related actoprotector-screen rows dropped
Still open
How should the reported heat-tolerance interaction with bromantane be read against classical stimulant failure under heat load?
How should doping-control analytical papers be read against the denser Russian animal pharmacology without collapsing the two genres?
Where does bemitil’s antihypoxant story stop overlapping with bromantane’s GABAergic / dopaminergic upregulation story?
Reviewed against the archive corpora on 2026-09-19. Source-grounded. No clinical claims. Archive / history / research only. No medical advice. No dosing, synthesis, sourcing, or health claims.
